Clinical Studies of Metabolic Bone Disease of Prematurity |
Seung-Yeon Suh1, Eun-Kyung Lee1, Ran Namgung1, Hae-Jung Joo1, Min-Soo Park1, Kook-In Park1, Chul Lee1, Dong-Gwan Han1, Meung-Jun Kim2, Jin-Suk Suh2 |
1Department of Pediatrics, College of Medicine, Yonsei University, Seoul, Korea 2Department of Radiology, College of Medicine, Yonsei University, Seoul, Korea |
미숙아 대사성골질환에 관한 임상 고찰 |
서승연1, 이은경1, 남궁란1, 주혜정1, 박민수1, 박국인1, 이철1, 한동관1, 김명준2, 서진석2 |
1연세대학교 의과대학 소아과학교실 2연세대학교 의과대학 진단방사선과학 |
|
|
Abstract |
Purpose : Preterm formula used in Korea, theoretically does not supply the recommended mineral intake for optimal bone metabolism in very low birth weight infants(Formula 500-700 mg Ca/L, 300~370mg P/L, and 440IU of vitamin D/L). The purpose of this study is to identify th e possible etiologic factors and clinical course of rickets in these infants.
Methods : We recently identified radiographic rickets or osteopenia in 16 VLBW infants over a 30-month period from January 1990, to July 1992. We performed a retrospective case analysis to evaluate the clinical features, nutritional status, biochemical and radiological findings o f metabolic disease in preterm infants.
Results : Mean gestational age and birth weight were 29¡¾2.1wks, and 1172¡¾245gm. All infants received parenteral nutrition and 11 infants needed assisted ventilation. Enteral feeding w as started at a mean age of 9.4¡¾11.0d and mean total calorie intakes were 62¡¾16.2kcal/kg/d in the first 2wks and 111¡¾26.9kcal/kg/d at 2-4 wks of age. Oral Ca/P intakes were severely restricted during the first month of life, and they were about 20% of recommended intakes of Ca/P for VLBW infants. At diagnosis of active rickets, serum Ca was high in 19% and serum P wa s low in 69% of infants. Serum alkaline phosphatase was increased in 56% and serum 25-hydroxyvitamin D was low in 67%. Active rickets was diagnosed at mean age of 38¡¾14.7 d; 12 infants had overt rickets(grade 2), including 3 infants with fractures(grade 3). Healing rickets was diagnosed on follow-up at mean age of 67.3¡¾22.0 days. Thus, metabolic bone disease of VLB W infants was associated with low mineral intakes compared to recommended intakes, and signs of P deficiency occurred at about 2 wks of age and persisted to 8 wks of age; hypercalcemia occurred initially, and these biochemical abnormalities precede the radiological abnormalities about 2 or 3 weeks.
Conclusion : Many factors are related to the development of metabolic hone disease of prematurity; one of the most important factor in our study was nutritional deficiency, especially m ineral(phosphorus) and vitamin D. In preterm VLBW infants whose adequate enteral feeding is restricted, mineral(calcium and phosphorus) and vitamin D supplementation would be needed t o reduce the development of metabolic bone disease in preterm infants. |
Key Words:
Metabolic bone disease, Preterm infants |
|